This lesson will teach students about ethical AI use. They will think about ways to identify responsible AI use and apply those understandings to their lives. Explain the ethical usage of AI and the ...

Starting a running routine doesn’t mean you need to go nonstop right away. One of the best ways to begin is with run/walk intervals. This method helps you build endurance gradually, stay consistent, ...

NSW government research shows 50 per cent of women experience harassment while running, while 95 per cent say safety issues influence their behaviour. An additional $500,000 has been allocated to the ...

The Department of Defense is expanding its use of Artificial Intelligence (AI) by formalizing Palantir Technologies’ Maven system as a long-term program, signaling a shift from experimental tools to ...

Amazon.com Inc. plans to use chips from startup Cerebras Systems Inc. alongside its own Trainium processors, a combination that the companies say will be able to better run AI software. Amazon Web ...

The drumbeat for the diminishing prospects of the first-run syndication business has been growing louder over the past few years amid a shrinking marketplace. Now, NBCUniversal has become the first ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...

In uncertain times, focus on your strengths and use AI to deepen customer trust, not chase distractions. Data-driven decisions and transparent communication help businesses stay resilient when ...

Customers lined up inside Goodblend in Plano at 10 a.m. Friday, waiting to buy medical marijuana available in gummies, tinctures and chocolate bars. A rush of customers isn't unusual for the shop, ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.